Kingsview Wealth Management LLC purchased a new position in shares of Nutrien Ltd. (NYSE:NTR – Free Report) in the second quarter, HoldingsChannel reports. The institutional investor purchased 16,247 shares of the company’s stock, valued at approximately $1,023,000.
A number of other institutional investors also recently added to or reduced their stakes in the stock. Guggenheim Capital LLC grew its stake in shares of Nutrien by 2.2% in the 4th quarter. Guggenheim Capital LLC now owns 6,628 shares of the company’s stock valued at $409,000 after purchasing an additional 145 shares during the period. Minot DeBlois Advisors LLC boosted its stake in Nutrien by 1.8% in the 4th quarter. Minot DeBlois Advisors LLC now owns 9,032 shares of the company’s stock valued at $557,000 after buying an additional 164 shares in the last quarter. Banque Cantonale Vaudoise grew its position in Nutrien by 15.9% in the first quarter. Banque Cantonale Vaudoise now owns 1,198 shares of the company’s stock valued at $90,000 after acquiring an additional 164 shares during the period. Gould Asset Management LLC CA raised its stake in Nutrien by 4.4% during the first quarter. Gould Asset Management LLC CA now owns 3,933 shares of the company’s stock worth $297,000 after acquiring an additional 165 shares in the last quarter. Finally, EverSource Wealth Advisors LLC raised its stake in Nutrien by 21.8% during the fourth quarter. EverSource Wealth Advisors LLC now owns 983 shares of the company’s stock worth $61,000 after acquiring an additional 176 shares in the last quarter. 63.10% of the stock is owned by institutional investors and hedge funds.
Nutrien Trading Up 0.8%
NYSE NTR opened at $73.64 on Friday. The company has a current ratio of 1.39, a quick ratio of 0.86 and a debt-to-equity ratio of 0.36. Nutrien Ltd. has a 12 month low of $53.03 and a 12 month high of $85.36. The company has a market capitalization of $35.23 billion, a PE ratio of 14.91, a P/E/G ratio of 0.78 and a beta of 0.61. The stock has a 50-day simple moving average of $67.33 and a 200 day simple moving average of $70.56.
Nutrien Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, October 16th. Shareholders of record on Tuesday, September 29th will be issued a $0.55 dividend. The ex-dividend date is Tuesday, September 29th. This represents a $2.20 annualized dividend and a yield of 3.0%. Nutrien’s dividend payout ratio (DPR) is 44.53%.
Nutrien News Summary
Here are the key news stories impacting Nutrien this week:
- Positive Sentiment: Zacks Research raised its FY2027 EPS estimate to $4.38 from $3.66, a substantial improvement that suggests stronger expected profitability. The firm also lifted estimates for Q2 2027, Q4 2027, FY2026, FY2028, Q1 2027, Q3 2027, Q4 2026 and Q2 2028. Collectively, the revisions point to improving longer-term earnings expectations.
- Positive Sentiment: An investor article emphasizes the appeal of not missing another year of Nutrien’s dividend income, which may reinforce the stock’s attraction to income-oriented investors. You’ve Already Missed a Year of Dividends: Here’s Why I Wouldn’t Miss Another
- Neutral Sentiment: Nutrien’s estimated current-year EPS remains below the broader consensus at $4.71 versus $4.95, while FY2027 and FY2028 estimates are $4.38 and $4.23, respectively. This indicates improving expectations but not an across-the-board bullish outlook.
- Negative Sentiment: Zacks Research reduced its Q3 2026 EPS estimate to $0.78 from $0.92 and its Q1 2028 estimate to $0.63 from $0.76. These cuts signal potential near-term earnings pressure and could limit the stock’s upside.
Analyst Ratings Changes
Several brokerages have recently commented on NTR. Berenberg Bank set a $65.00 target price on shares of Nutrien and gave the company a “hold” rating in a research note on Wednesday, June 10th. Scotiabank upgraded shares of Nutrien from a “sector perform” rating to a “sector outperform” rating and set a $80.00 price target on the stock in a research report on Tuesday, June 30th. Morgan Stanley decreased their price objective on shares of Nutrien from $93.00 to $81.00 and set an “overweight” rating on the stock in a research note on Tuesday, July 7th. TD Securities reaffirmed a “buy” rating on shares of Nutrien in a report on Wednesday, May 6th. Finally, Oppenheimer reduced their target price on Nutrien from $82.00 to $80.00 and set an “outperform” rating on the stock in a report on Thursday, July 23rd. Seventeen equities research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Nutrien has a consensus rating of “Moderate Buy” and an average target price of $81.58.
View Our Latest Report on Nutrien
About Nutrien
Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.
Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.
Read More
- Five stocks we like better than Nutrien
- From SaaS-pocalypse to Perfect Storm: Workday’s AI Growth Story Strengthens
- These 3 GARP Stocks Show Why Growth and Value Do Not Have to Clash
- Venture Into High-Volatility Corners of the Market With These 3 ETFs
- 3 Retail Stocks to Watch After a Big Consumer Earnings Week
Want to see what other hedge funds are holding NTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutrien Ltd. (NYSE:NTR – Free Report).
Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.
